Form 4 for NKE Nike, Inc.
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-03 · accession 0001127602-21-028474 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-05 | 2021-11-03 | NKE | PARKER MARK G | EXECUTIVE COB, Dir | S - Sale+OE | $171.37 | -60.0K | 1.41M | -4% | -$10.28M |
| DM | 2021-11-05 | 2021-11-03 | NKE | PARKER MARK G | EXECUTIVE COB, Dir | M - OptEx | $23.27 | +60.0K | 1.43M | +4% | +$1.40M |
| DM | 2021-11-05 | 2021-11-03 | NKE | PARKER MARK G | EXECUTIVE COB, Dir | M - OptEx | $0.00 | -60.0K | 296.9K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class B Common Stock | 2021-11-03 | S | D | 13,570 | $172.54 | 1,405,824 | D | — | — | (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.05 to $172.775, inclusive. |
| 2 | Common | Class B Common Stock | 2021-11-03 | M | A | 13,570 | $23.27 | 1,419,394 | D | — | — | (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. |
| 3 | Common | Class B Common Stock | 2021-11-03 | M | A | 23,302 | $23.27 | 1,429,126 | D | — | — | (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. |
| 4 | Common | Class B Common Stock | 2021-11-03 | S | D | 23,128 | $170.70 | 1,405,824 | D | — | — | (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $171.00, inclusive. The reporting person undertakes to provide NIKE, Inc., any security holder of NIKE, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (2), (3) and (4) to this Form 4. |
| 5 | Common | Class B Common Stock | 2021-11-03 | M | A | 23,128 | $23.27 | 1,428,952 | D | — | — | (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. |
| 6 | Common | Class B Common Stock | 2021-11-03 | S | D | 23,302 | $171.35 | 1,405,824 | D | — | — | (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.01 to $172.005, inclusive. |
| 7 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2021-11-03 | M | D | 23,302 | $0.00 | 273,570 | D | $23.27 · — to 2022-07-20 | 23,302 Class B Common Stock | (F6) Stock Option granted on 07/20/2012 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant. |
| 8 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2021-11-03 | M | D | 13,570 | $0.00 | 260,000 | D | $23.27 · — to 2022-07-20 | 13,570 Class B Common Stock | (F6) Stock Option granted on 07/20/2012 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant. |
| 9 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2021-11-03 | M | D | 23,128 | $0.00 | 296,872 | D | $23.27 · — to 2022-07-20 | 23,128 Class B Common Stock | (F6) Stock Option granted on 07/20/2012 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant. |